NEW YORK--(BUSINESS WIRE)--Pragma Pharmaceuticals is pleased to announce that it is planning the launch of Decadron ® (dexamethasone) .5, .75, 4 and 6 mg tablets in early 2018.

The FDA has approved labeling revisions for dexamethasone (Decadron), morphine (Duramorph and Infumorph), several antidepressants, and amino acid injection solution with electrolytes (3% and 8.5% ...